# Frequent Hemodialysis Network: Daily Trial

> **NCT00264758** · PHASE2,PHASE3 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 245 (actual)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **DEVICE:** Conventional hemodialysis
- **DEVICE:** Frequent hemodialysis

## Key facts

- **NCT ID:** NCT00264758
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 245 (ACTUAL)
- **Last updated:** 2014-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00264758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00264758, "Frequent Hemodialysis Network: Daily Trial". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00264758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*